Sigyn Therapeutics reports conversion of $226,903 in debentures at $6.00 per share, issuing 37,820 shares.

Sigyn Therapeutics, Inc.

Holders converted $226,903 of Original Issue Discount Senior Convertible Debentures at avg. exercise price of $6.00/share.
Company issued 37,820 shares of common stock to debenture holders.
Outstanding common shares increased from 1,225,833 to 1,263,653 as a result.
Conversions occurred from May 30 to June 6, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.